Endovascular treatment of above the knee and popliteal arteries

Abstract

Endovascular therapy of the femoropopliteal arterial segment has matured substantially over the recent years. The introduction of dedicated wire technology, reentry devices, as well as bare and drug-eluting Nitinol stents has substantially improved technical opportunities and clinical outcomes. Current technological improves are directed at further reductions of restenosis rates in this challenging arterial segment.